DOES ONE SIZE FIT ALL? RISKS AND BENEFITS OF NEOADJUVANT CHEMORADIATION IN PATIENTS WITH CLINICAL STAGE II RECTAL CANCER REQUIRING ABDOMINOPERINEAL RESECTION.

Xhaja X.; Benson D.; Dietz D.; Stocchi L.; Kalady M.; Ashburn J.; Lavery I.; Remzi F.

首页> 外文期刊>Diseases of the Colon and Rectum >DOES ONE SIZE FIT ALL? RISKS AND BENEFITS OF NEOADJUVANT CHEMORADIATION IN PATIENTS WITH CLINICAL STAGE II RECTAL CANCER REQUIRING ABDOMINOPERINEAL RESECTION.

【24h】

DOES ONE SIZE FIT ALL? RISKS AND BENEFITS OF NEOADJUVANT CHEMORADIATION IN PATIENTS WITH CLINICAL STAGE II RECTAL CANCER REQUIRING ABDOMINOPERINEAL RESECTION.

机译：一码适合吗？需要进行腹膜会阴切除的II期临床直肠癌患者的新辅助化学放疗的风险和益处。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diseases of the Colon and Rectum 》 |2015年第5期| 共2页
作者
Xhaja X.; Benson D.; Dietz D.; Stocchi L.; Kalady M.; Ashburn J.; Lavery I.; Remzi F.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. DOES ONE SIZE FIT ALL? RISKS AND BENEFITS OF NEOADJUVANT CHEMORADIATION IN PATIENTS WITH CLINICAL STAGE II RECTAL CANCER REQUIRING ABDOMINOPERINEAL RESECTION. [J] . Xhaja X., Benson D., Dietz D., Diseases of the Colon and Rectum . 2015 ,第5期

机译：一码适合吗？需要进行腹膜会阴切除的II期临床直肠癌患者的新辅助化学放疗的风险和益处。
2. SURVIVAL BENEFITS OF SALVAGE SURGERY FOR DISTANT TREATMENT FAILURE IN RECTAL CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMORADIATION AND CURATIVE-INTENT RESECTION. [J] . Liles J., You Y., Cuddy A., Diseases of the Colon and Rectum . 2015 ,第5期

机译：接受新辅助化学疗法和治疗性切除术治疗的直肠癌患者远距离治疗失败的挽救性手术的生存优势。
3. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single‐institution study with propensity score‐matched comparative analysis [J] . Sun Xi‐yu, Cai Song‐hua, Xu Lai, Asia-Pacific journal of clinical oncology . 2020 ,第3期

机译：Neoadjuvant ChemorAdiotaMatia治疗IIIB / IIIC局部晚期癌症患者的生存益处：回顾性单机构研究，具有倾向分数匹配比较分析
4. Texture kinetic features from pre-treatment DCE MRI for predicting pathologic tumor stage regression after neoadjuvant chemoradiation in rectal cancers [C] . Siddhartha Nanda, Jacob T. Antunes, Kaustav Bera, Conference on Medical Imaging: Image-Guided Procedures, Robotic Interventions, and Modeling . 2020

机译：预处理DCE MRI的纹理动力学特征可预测直肠癌新辅助化学放疗后病理性肿瘤分期
5. The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center (Ontario). [D] . Sinclair, Suzanne Marie. 2003

机译：金斯敦地区癌症中心（安大略省）对III期非小细胞肺癌患者进行化学放射治疗的有效性。
6. Thymidine phosphorylase and hypoxia-inducible factor 1-α expression in clinical stage II/III rectal cancer: association with response to neoadjuvant chemoradiation therapy and prognosis [O] . Shuhan Lin, Hao Lai, Yuzhou Qin, 2015

机译：胸苷磷酸化酶和缺氧诱导因子1-α在临床II / III期直肠癌中的表达：与新辅助化学放疗反应和预后的关系
7. A predictive genetic signature for response to fluoropyrimidine-based neoadjuvant chemoradiation in clinical Stage II and III rectal cancer [O] . Jason eChan, Michael eKinsella, Joseph eWillis, 2013

机译：基于氟嘧啶的新辅助化放疗对临床II期和III期直肠癌反应的预测性遗传特征

DOES ONE SIZE FIT ALL? RISKS AND BENEFITS OF NEOADJUVANT CHEMORADIATION IN PATIENTS WITH CLINICAL STAGE II RECTAL CANCER REQUIRING ABDOMINOPERINEAL RESECTION.

著录项

相似文献

相关主题

期刊订阅